Publikationen in Zusammenarbeit mit Forschern von Montreal Heart Institute (11)

2024

  1. Outcomes after surgical revascularization in diabetic patients

    Interdisciplinary cardiovascular and thoracic surgery, Vol. 38, Núm. 2

  2. Transatlantic analysis of patient profiles and mid-term survival after isolated coronary artery bypass grafting: a head-to-head comparison between the European DuraGraft Registry and the US STS Registry

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. A multicentre, propensity score matched analysis comparing a valve-sparing approach to valve replacement in aortic root aneurysm: Insight from the AVIATOR database

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 63, Núm. 2

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort study

    International journal of surgery (London, England), Vol. 109, Núm. 4, pp. 707-715

2022

  1. Clinical event rate in patients with and without left main disease undergoing isolated coronary artery bypass grafting: results from the European DuraGraft Registry

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 62, Núm. 4

2021

  1. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

2019

  1. A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: Protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry

    Journal of Cardiothoracic Surgery, Vol. 14, Núm. 1

  2. Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR

    Seminars in Thoracic and Cardiovascular Surgery, Vol. 31, Núm. 4, pp. 643-649

  3. The AVIATOR registry: The importance of evaluating long-term patient outcomes

    Annals of Cardiothoracic Surgery

2015

  1. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7